Muriel Vray

Muriel Vray is a Researcher at the Institut Pasteur's Department of Epidemiology of Emerging Diseases. She specializes in infectious disease epidemiology, vaccine implementation, and clinical trial design in resource-limited settings. Her work focuses on hepatitis B prevention, malaria-HIV co-infections, and maternal-child health across sub-Saharan Africa and South Asia.

• Principal Investigator for Neovac (Hepatitis B vaccination in Africa)
• Collaborator in Pasteur-Cnam-EHESP School of Public Health
• Currently researching point-of-care diagnostics for hepatitis B vertical transmission

Research Trends from her publications include: hepatitis B vaccine program evaluation, antimicrobial resistance in maternal health, and vaccine acceptance behavioral analysis. Her recent 2024-2025 studies emphasize multi-country diagnostic accuracy and co-infection molecular characterization.